| 107 | 0 | 883 |
| 下载次数 | 被引频次 | 阅读次数 |
颈动脉粥样硬化(carotid atherosclerosis,CAS)的病程演变呈现较明晰的阶段性特征，从颈动脉内膜中层增厚，进展为斑块形成，最终可导致颈动脉狭窄和(或)诱发心脑血管事件。姚魁武教授从“寒伏致瘀”论治CAS，融汇寒病理论与现代医学，提出CAS的病理因素早期以“气郁”“痰浊”为先，中期以“瘀血”“痰浊”为主，后期以“瘀血”“毒邪”为要;确立“温阳化斑”治疗大法，在CAS早期、中期、后期分别采取“启阳开郁，调气化浊”“温阳运中，行滞化斑”“助阳通脉，化毒稳斑”的辨治策略。
Abstract：The progression of carotid atherosclerosis( CAS) exhibits distinct stages,starting with thickening of the carotid intimamedia,progressing to plaque formation,and eventually leading to carotid stenosis and/or triggering cardiovascular and cerebrovascular events. Professor Yao Kuiwu treats CAS based on the theory of " latent Cold induced blood stasis",integrating cold disease theory with modern medicine. He proposes that in the early stage of CAS,pathological factors are primarily " Qi stagnation" and " Phlegm and Turbidity"; in the middle stage, " blood stasis" and " Phlegm and Turbidity" are predominant; and in the late stage, " blood stasis" and "Toxin Evil Factor" are the key ones. He established the major treatment principle of " warming Yang to transform plaques",adopting differentiated treatment strategies at different stages of CAS: " invigorating Yang to release stagnation and regulating Qi to resolve turbidity" in the early stage, " warming Yang to promote Zhong Qi and eliminating stagnation to transform plaques" in the middle stage,and "assisting Yang to dredge meridians and detoxify to stabilize the condition without plaques" in the late stage.
[1]LIBBY P,RIDKER P M,HANSSON G K. Inflammation in atherosclerosis[J]. J Am Coll Cardiol,2009,54(23):2129-2138.
[2]《老年人颈动脉粥样硬化性疾病诊治中国专家建议》写作组，中华医学会老年医学分会，《中华老年医学杂志》编辑委员会，等．老年人颈动脉粥样硬化性疾病诊治中国专家建议[J]．中华老年医学杂志，2013,32(2):113-120.
[3]STEIN J H,KORCARZ C E,HURST R T,et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk:a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine[J]. J Am Soc Echocardiogr,2008,21(2):93-111.
[4]FU J Z,DENG Y H,MA Y,et al. National and provinciallevel prevalence and risk factors of carotid atherosclerosis in Chinese adults[J]. JAMA Netw Open,2024,7(1):e2351225.
[5]CLARKE R,DU H D,KURMI O,et al. Burden of carotid artery atherosclerosis in Chinese adults:Implications for future risk of cardiovascular diseases[J]. Eur J Prev Cardiol,2017,24(6):647-656.
[6]METHAROM P,CAPLICE N. Vascular disease:a new progenitor biology[J]. Curr Vasc Pharmacol,2007,5(1):61-68.
[7]杨靖，王克强，霍勇，等．泛血管疾病综合防治科学声明[J]．中国循环杂志，2019,34(11):1041-1046.
[8]MENDIETA G,POCOCK S,MASS V,et al. Determinants of progression and regression of subclinical atherosclerosis over6 years[J]. J Am Coll Cardiol,2023,82(22):2069-2083.
[9]中华心血管病杂志编辑委员会．动脉粥样硬化斑块的筛查与临床管理专家共识[J]．中华心血管病杂志，2022,5(1):1-13.
[10]国家卫生健康委员会脑卒中防治专家委员会血管超声专业委员会，中国超声医学工程学会浅表器官及外周血管超声专业委员会，中国超声医学工程学会颅脑及颈部血管超声专业委员会．头颈部血管超声若干问题的专家共识(颈动脉部分)[J]．中国脑血管病杂志，2020,17(6):346-353.
[11]陈忠，杨耀国．颈动脉狭窄诊治指南[J]．中国血管外科杂志(电子版)，2017,9(3):169-175.
[12]JOHANNESEN C D L,MORTENSEN M B,LANGSTED A,et al. Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients[J]. J Am Coll Cardiol,2021,77(11):1439-1450.
[13]REIFF T,ECKSTEIN H H,MANSMANN U,et al. Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis:5-year results of a multicentre,randomised controlled trial[J]. Lancet Neurol,2022,21(10):877-888.
[14]LI J J,DOU K F,ZHOU Z G,et al. Chinese expert consensus on the clinical diagnosis and management of statin intolerance[J]. Clin Pharmacol Ther,2024,115(5):954-964.
[15]PARASKEVAS K I,GLOVICZKI P,ANTIGNANI P L,et al. Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease[J]. Prog Cardiovasc Dis,2022,73:41-47.
[16]张笑霄，林建国，孙晓宁，等．中医学寒病理论的源流探析与体系构建[J]．环球中医药，2025,18(1):37-44.
[17]陈洁，姚美丹，黄尉威，等．基于冠状动脉病变程度、颈动脉超声及中医证候要素探讨血脉理论[J]．北京中医药大学学报，2023,46(3):406-414.
[18]任耀龙，陈玲，杨磊，等．冠心病合并颈动脉粥样硬化斑块形成病人中医证素分布规律研究[J]．中西医结合心脑血管病杂志，2019,17(19):2881-2885.
[19]何丽敏，喻颖，陈炀，等．基于因子分析和聚类分析的伴颈动脉硬化的脑卒中高危人群中医证素研究[J]．环球中医药，2025,18(5):942-951.
[20]VLAJINAC H D,MARINKOVIC J M,MAKSIMOVIC M Z,et al. The prevalence of polyvascular disease in patients with carotid artery disease and peripheral artery disease[J]. Kardiol Pol,2019,77(10):926-934.
基本信息:
DOI：10.16368/j.issn.1674-8999.2026.01.004
中图分类号:R249;R259
引用信息:
[1]张笑霄,肖烨,黄梦文,等.姚魁武从“寒伏致瘀”分期辨治颈动脉粥样硬化[J].中医学报,2026,41(01):20-24.DOI:10.16368/j.issn.1674-8999.2026.01.004.
基金信息:
癌症、心脑血管、呼吸和代谢性疾病防治研究国家科技重大专项项目(四大慢病重大专项)(2024ZD0528300,2024ZD0528304); 2024年岐黄学者培养项目(中医药领军人才培养项目){国中医药人教函[2025]182号}; 北京市自然科学基金项目(7232324); 中国中医科学院科技创新工程项目(CI2021B004)
2026-01-09
2026-01-09